Sidley Austin represented AdvanCell in the transaction, and Kirkland & Ellis represented Eli Lilly and Company.AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
